Tool companies make money on a straightforward business model: they sell their patented tools to companies who use them in research. Companies who don't pay for the right to access those innovations, but make them on their own, using them for research, are infringing the tool companies' patents.
Or are they? In what was clearly a blow for tool companies and a boost for drug developers, the Supreme...